Name of applicant: |
Hikma Pharmaceuticals PLC |
Name of scheme: |
Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP") & Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP") & Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("MIP") & Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP") |
Period of return |
From: |
1 April 2019 |
To: |
31 September 2019 |
Balance of unallotted securities under scheme(s) from previous return: |
SOP: 792,700 ordinary shares of 10 pence LTIP: 102,714 ordinary shares of 10 pence MIP: 770,393 ordinary shares of 10 pence EIP: 1,541,128 ordinary shares of 10 pence |
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
SOP: 0 ordinary shares of 10 pence LTIP: 0 ordinary shares of 10 pence MIP: 0 ordinary shares of 10 pence EIP: 0 ordinary shares of 10 pence |
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
SOP: 0 ordinary shares of 10 pence LTIP: 0 ordinary shares of 10 pence MIP: 237,176 ordinary shares of 10 pence EIP: 429,828 ordinary shares of 10 pence |
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
SOP: 792,700 ordinary shares of 10 pence LTIP: 102,714 ordinary shares of 10 pence MIP: 533,217 ordinary shares of 10 pence EIP: 1,111,300 ordinary shares of 10 pence |
| |
|
|
|
|
